SNHG7 and diabetic retinopathy: reported that exosomal SNHG7 from MSCs inhibits endothelial‐mesenchymal transition and angiogenesis in diabetic retinopathy by targeting the miR‐34a‐5p/XBP1 pathway (Cao et al. 2021).